Eating disorders have among the highest mortality rates of any psychiatric illness, yet even the best available treatments produce full recovery in only about 30% of patients with anorexia nervosa. The reasons aren’t simple. Biology, psychology, genetics, and practical barriers all converge to make these disorders uniquely resistant to treatment, often reinforcing each other in ways that keep people stuck for years.
The Brain Rewires Itself Around the Disorder
Eating disorders physically change how the brain processes reward, hunger, and anxiety. In anorexia, food restriction appears to sensitize the brain’s reward and salience pathways, particularly in the insula (a region involved in body awareness and taste processing) and the striatum (which handles motivation and reward). Over time, these changes drive food avoidance at a biological level, meaning willpower alone can’t override what the brain is doing automatically.
Bulimia nervosa involves a different pattern. Repeated cycles of binge eating and purging dampen the brain’s ability to process prediction errors, the signals that help you learn from experience and adjust behavior. The more frequently someone binges and purges, the weaker this signal becomes. That creates a vicious cycle: the behavior itself degrades the neural machinery that would normally help a person recognize the behavior isn’t working and change course.
Dopamine, the neurotransmitter most associated with motivation and reward, is also disrupted. People with anorexia show altered dopamine metabolite levels and changes in the number of dopamine receptors in key brain regions. These aren’t just consequences of being underweight. Structural and functional differences in the insula, orbitofrontal cortex, and cingulate cortex may actually predispose someone to developing an eating disorder in the first place, and then malnutrition or binge-purge cycles deepen those changes further.
Many Patients Don’t Believe They’re Sick
One of the most frustrating barriers to treatment is that eating disorders often feel consistent with a person’s identity and values rather than like an illness imposed on them. Clinicians call this “ego-syntonic,” and it’s fundamentally different from conditions like depression, where patients usually recognize something is wrong.
In anorexia, this goes further into something resembling anosognosia, a neurological inability to recognize one’s own condition. Despite extreme low body weight and serious medical complications, many people with anorexia genuinely deny being ill. They may acknowledge secondary symptoms like fatigue, vomiting, or gastrointestinal pain, but consistently fail to connect those problems to their restrictive eating. The symptoms feel like separate issues rather than consequences of starvation.
Recent research frames this as a problem with how the brain updates its model of the body. The persistent belief of being overweight functions as a deeply entrenched prior expectation. Normally, incoming sensory information (proprioceptive signals from muscles and joints, interoceptive signals about hunger and energy) would correct that belief. But in anorexia, these internal signals get downweighted in favor of visual, external information. The brain essentially refuses to update its body image even when internal signals are screaming that the body is dangerously underweight. People with anorexia may have declarative knowledge of their condition, understanding intellectually that their weight is low, but they don’t experience it as real. They behave as if they are not ill.
This creates an obvious treatment problem. It’s extraordinarily difficult to motivate someone toward recovery when their brain is telling them nothing is wrong.
Genetics Load the Gun
Eating disorders run in families, and twin studies confirm a substantial genetic component. Heritability estimates for anorexia range from 28% to 74%, with adolescent female twins at the higher end. Bulimia has an even stronger genetic signal, with heritability estimates between 54% and 83%. Binge eating disorder falls in the 41% to 57% range.
These numbers matter for treatment because they mean eating disorders aren’t purely behavioral problems that can be solved by changing habits or thinking patterns. A significant portion of vulnerability is baked into a person’s biology before they ever restrict a meal or begin purging. Treatment has to work against genetic predispositions that influence everything from anxiety levels to how the brain responds to food cues, and those predispositions don’t disappear when symptoms improve. They remain as ongoing risk factors for relapse.
Most Patients Have Other Psychiatric Conditions
More than 70% of people with eating disorders also meet criteria for at least one other psychiatric condition. Over half have a personality disorder. More than half have an anxiety disorder. Over 40% have a mood disorder like depression. And more than 10% struggle with substance abuse. These aren’t coincidental. Eating disorder behaviors often serve as coping mechanisms for these underlying conditions, so treating the eating disorder without addressing anxiety or trauma can feel like taking away someone’s only tool for managing distress.
Comorbidities also complicate treatment logistics. A person dealing with severe anxiety and anorexia simultaneously needs a treatment approach that addresses both, and progress in one area can temporarily worsen the other. Someone who used restriction to manage anxiety, for example, may experience a surge in panic symptoms during refeeding. Without adequate support for that anxiety, they’re likely to relapse.
Recovery Itself Is Physically Dangerous
For severely malnourished patients, the early phase of treatment carries real medical risk. Refeeding syndrome occurs when reintroducing nutrition after extended starvation triggers dangerous shifts in electrolytes and fluid balance. As the body begins processing food again, rising glucose triggers an insulin surge that pulls phosphorus and potassium into cells, depleting what’s available in the bloodstream.
The consequences can be severe. Low potassium can cause cardiac arrhythmias, muscle weakness, respiratory distress, and paralysis. Low phosphorus decreases the heart’s ability to contract normally, reduces oxygen delivery to tissues, and in severe cases causes acute respiratory failure. Magnesium depletion worsens both of these problems and adds neurological symptoms like vertigo, convulsions, and depression. Together, low magnesium and potassium can trigger a potentially fatal heart rhythm called torsades de pointes. Thiamine deficiency, also common during refeeding, can cause memory impairment and brain damage.
This means treatment can’t simply begin with “eat more.” Nutritional rehabilitation has to be carefully managed and medically supervised, which slows the process, increases cost, and adds another layer of fear for patients who are already terrified of gaining weight.
Current Treatments Have Limited Success
The gold-standard psychological treatment for eating disorders is an enhanced form of cognitive behavioral therapy. For bulimia and binge eating disorder, it works reasonably well. But for anorexia, the numbers are sobering. In one implementation study at a specialized outpatient unit, 69% of anorexia patients dropped out of treatment entirely. Only 27% of all enrolled patients achieved recovery, defined as reaching a healthy BMI and scoring below the clinical threshold on a standardized eating disorder questionnaire.
The picture improves dramatically for those who actually complete treatment. In that same study, 78% of completers recovered, compared to just 12.5% of those who dropped out. A larger randomized trial found that about 60% of anorexia patients completed their assigned therapy. The pattern is consistent: treatment can work, but keeping people engaged long enough is the central challenge. The biological, psychological, and identity-level factors described above all conspire to push patients out of treatment before it has a chance to help.
Long-term follow-up data offers some encouragement alongside caution. In a 22-year study, most patients who achieved recovery maintained it. But 10.5% of recovered anorexia patients and 20.5% of recovered bulimia patients relapsed after their first decade of recovery, showing that vulnerability persists for years even after successful treatment.
Treatment Is Expensive and Hard to Access
Residential and inpatient eating disorder treatment costs an average of $2,000 per day. Intensive outpatient programs run about $1,500 per week. The University of California San Diego estimates that a typical treatment episode costs $80,000. These aren’t optional luxuries. Many patients cycle through multiple levels of care over several years.
Insurance coverage is unreliable. Private plans often include level-of-care exclusions, approve only short-term stays, or impose medical necessity requirements that don’t align with how eating disorders actually progress. Government insurance like Medicare and Medicaid almost universally excludes everything between basic outpatient visits and full hospitalization, leaving the entire middle spectrum of care (partial hospitalization, residential treatment, intensive outpatient) inaccessible. This gap disproportionately affects low-income and disabled patients. According to Project HEAL, the number of people who have the personal funds or insurance coverage to complete a full course of treatment without unfair denials may be in the hundreds.
The result is that many patients receive fragmented care: a few weeks of residential treatment followed by abrupt discharge when insurance runs out, with inadequate step-down support. For a condition that requires sustained, intensive intervention, this pattern sets people up for relapse before they’ve had a real chance at recovery.